Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products for aesthetic dermatology. The company currently has a rich pipeline of products focusing on treatments for wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying. In the future, Eirion plans to also pursue additional indications that address other major unmet clinical needs for physicians and their patients.



Education

Biotechnology

Eirion Therapeutics

Eirion Therapeutics' headquarters in Woburn, MA, United States

Jon Edelson

Mary Senica

Klaus Theobald

Albert Hummel

Carter Meyer

Kevin Finney

Barry Kurokawa

Leadership Team

Eirion Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Offices

Similar companies